GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anteris Technologies Global AVR.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

8.25

+0.61%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.9m

FY2016FY2025

Net income

−$94.0m

FY2016FY2025

Free cash flow

−$80.0m

FY2016FY2025

Shareholders' equity

−$90,000

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.9m$2.7m$7.0m$6.7m$9.3m$9.6m$17.2m$25.7m$11.7m$22.5m
Research and development——$22.9m$13.2m$8.0m$4.6m$3.3m$3.4m$597,600$1.8m
Operating income−$94.0m−$78.1m−$67.7m−$45.2m−$21.5m−$14.3m−$24.9m−$24.6m−$8.5m−$12.2m
Net income−$94.0m−$76.0m−$67.3m−$44.3m−$22.9m−$15.3m−$5.8m−$24.2m−$8.6m−$12.3m
Diluted earnings per share-2.55-2.12-1.87-1.23-3.09-2.58-0.99-7.93-3.39-4.90

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$23.0m—$45.7m$23.5m$29.5m$12.7m$26.0m$31.9m$28.4m$28.6m
Cash and short-term investments$13.0m—$30.8m$13.8m$21.3m$4.4m$16.1m$12.0m$8.3m$11.3m
Total liabilities$23.0m—$17.1m$10.3m$15.1m$10.2m$10.5m$10.7m$14.3m$5.6m
Debt$40,000—$2.5m$2.8m$6.9m$4.7m$3.6m—$5.0m—
Shareholders' equity−$90,000—$28.6m$13.2m$14.3m$2.4m$15.5m$21.1m$14.1m$22.9m
Shares outstanding37m36m36m36m7m6m6m3m3m3m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$78.0m—−$51.4m−$39.0m−$18.8m−$14.4m−$22.9m−$22.2m−$6.6m−$12.5m
Capital spending−$1.9m—−$3.6m−$2.4m−$772,700−$288,500−$67,200−$611,200−$1.1m−$268,900
Free cash flow−$80.0m—−$55.0m−$41.4m−$19.6m−$14.7m−$22.9m−$22.8m−$7.8m−$12.7m

Latest quarters

By quarter end

Jun 2024Dec 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Dec 2021
Revenue$2.9m$4.2m$2.8m$1.2m$3.7m$1.1m$3.0m$6.0m
Operating income−$54.2m−$37.2m−$30.5m−$15.6m−$23.1m−$12.5m−$22.2m−$11.7m
Net income−$50.8m−$37.1m−$30.3m−$15.1m−$22.2m−$11.1m−$22.1m−$12.5m
Diluted earnings per share-2.75-1.03-2.01-1.00-1.59-0.80-1.73-1.52
Total assets$26.5m$45.7m$33.9m$33.9m$23.5m$23.5m$43.1m$29.5m
Cash and short-term investments$10.8m$30.8m$20.3m$20.3m$13.8m$13.8m$33.1m$21.3m
Debt$1.7m$1.5m$3.1m$2.2m$2.0m$649,000$2.3m$1.6m
Shareholders' equity$5.7m$28.6m$21.1m$21.6m$13.2m$13.2m$31.2m$14.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-34.3%-27.5%-18.3%
Operating income27.6%45.7%14.1%
Net income28.5%43.8%14.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-3733.2%-1552.3%-862.8%-323.5%
Net margin-3687.6%-1533.9%-859.9%-307.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-2.2-2.8-7.4-13.1-3.0-1.1
Price to sales107.679.871.086.07.51.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1-to-1 reverse split · 6 Dec 2024
  • 100-to-1 reverse split · 2 Mar 2020
  • 10-to-1 reverse split · 17 Nov 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.